Trial Profile
A Study Assessing the Effect of Early Versus Late Treatment Intensification with Dapagliflozin in U.K. Primary Care Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2019
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2018 New trial record
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association.